Rosiglitazone Maleate Market

Rosiglitazone maleate is an insulin sensitizer. Rosiglitazone maleate activates luciferase-based expression constructs PPAR?1 and PPAR?2 with EC50 values of approximately 30 nM and 100 nM, respectively. Rosiglitazone maleate (Avandia) improves glycemic control while reducing circulating insulin levels. Rosiglitazone maleate also appears to have an anti-inflammatory effect in addition to its effect on insulin resistance. Rosiglitazone maleate is active in vivo as an antidiabetic agent in the ob/ob mouse model, and has been used as an oral hypoglycemic agent in the treatment of Type II diabetes in humans for many years.
Rosiglitazone Maleate Market contains market size and forecasts of Rosiglitazone Maleate in global, including the following market information:
Global Rosiglitazone Maleate Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Rosiglitazone Maleate Market Sales, 2017-2022, 2023-2028, (Tons)
Global top five Rosiglitazone Maleate companies in 2021 (%)
The global Rosiglitazone Maleate market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Purity 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Rosiglitazone Maleate include AbMole BioScience, Aceto, AdooQ BioScience., Biosynth Carbosynth, BLDpharm, FUJIFILM Wako Pure Chemical Corporation, Krackeler Scientific, LKT Laboratories and Lucerna-Chem, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Rosiglitazone Maleate manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Rosiglitazone Maleate Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Rosiglitazone Maleate Market Segment Percentages, by Type, 2021 (%)
Purity 98%
Purity 99%
Global Rosiglitazone Maleate Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Rosiglitazone Maleate Market Segment Percentages, by Application, 2021 (%)
Medicine
Chemical
Other
Global Rosiglitazone Maleate Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Rosiglitazone Maleate Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Rosiglitazone Maleate revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Rosiglitazone Maleate revenues share in global market, 2021 (%)
Key companies Rosiglitazone Maleate sales in global market, 2017-2022 (Estimated), (Tons)
Key companies Rosiglitazone Maleate sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbMole BioScience
Aceto
AdooQ BioScience.
Biosynth Carbosynth
BLDpharm
FUJIFILM Wako Pure Chemical Corporation
Krackeler Scientific
LKT Laboratories
Lucerna-Chem
Tecoland Corporation
XpressBio